A Comparison of Sedation with Dexmedetomidine and Midazolam during Infraclavicular Block in Upper Limb Surgeries: A Randomized Controlled Clinical Trial

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250106064297N1

Enrollment

Registered

2025-02-24

Start date

2025-02-19

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper limb surgeries.

Interventions

Intervention 1: Control group: Midazolam. Intervention 2: Intervention group: Dexmedetomidine.

Eligibility

Sex/Gender

All

Age

18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Patients who are candidates for hand, wrist, and forearm surgery2. Patients between the ages of 18 and 55 years old3. Patients with ASA Class I, II4. No history of previous echocardiography and endoscopy5. No need for emergency echocardiography6. Not pregnant7. Patients not on mechanical ventilation8. Absence of psychological disorders in patients9. No addictions10. No history of allergic reactions

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Blood pressure, heart rate, saturation, pain intensity, sedation with dexmedetomidine-midazolam during infraclavicular block in upper limb surgeries. Timepoint: Year 2024-2025. Method of measurement: Researcher-made checklist based on study objectives and hypotheses.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactbabak kosar

Khoram-Abad University of Medical Sciences

doctorchi.chi1994@gmail.com+98 21 8670 5503

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026